Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

CME Outfitters

Clinical Insights on Recent Advances in Spinal Muscular Atrophy

Access Activity

Overview / Abstract:

Spinal muscular atrophy (SMA) is a leading, fatal, autosomal recessive disorder that affects approximately one in 10,000 live births. Nusinersen was approved as the first targeted therapy for SMA, and since its groundbreaking approval data has been published that demonstrates its efficacy for both infantile- and later-onset SMA populations. Additionally, recent guidelines were published that provide evidence-based recommendations for the diagnosis and management of SMA.

However, despite these advances there are knowledge gaps among health care providers (HCPs) regarding current data on safety and efficacy of approved and emerging therapies, which can result in treatment delays. Closing these gaps will promote early and accurate diagnosis and optimal treatment of patients with SMA.

In this CME Outfitters live and on demand webcast, expert faculty will host a case-based panel discussion that focuses on screening and early diagnosis of SMA and the importance of utilizing the latest clinical data on the efficacy and safety of approved and emerging therapies.

Learning Objectives

At the end of this CE activity, participants should be able to:

- Review the pathophysiology and therapeutic targets of SMA.
- Apply the current recommendations for screening and early diagnosis of SMA.
- Evaluate the latest clinical data on the efficacy and safety of approved and emerging therapies for SMA.

The following learning objectives pertain only to those requesting CNE or CPE credit:

- Review the pathophysiology and therapeutic targets of SMA.
- Describe the current recommendations for screening and early diagnosis of SMA.
- Evaluate the latest clinical data on the efficacy and safety of approved and emerging therapies for SMA.

Expiration

Jan 07, 2021

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE

Credits / Hours

1.5 AMA PRA Category 1 Credit(s)™

Accreditation

ACCME, AANP, ACPE, AAPA, MACRA, ABIM, ABPN

Presenters / Authors / Faculty

Emma Ciafaloni, MD, FAAN
Robert C. and Rosalyne H. Griggs Professor in Experimental Therapeutics of Neurologic Disease
Professor of Neurology, Pediatrics and Obstetrics and Gynecology
Director, Pediatric Neuromuscular Medicine
University of Rochester, School of Medicine and Dentistry
Rochester, NY

Activity Specialities / Related Topics

Primary Care, Pediatrics, OB/GYN / Women's Health, Neurology, Family Medicine

Sponsors / Supporters / Grant Providers

Supported by educational grants from Biogen MA, Inc. and Genentech.

Keywords / Search Terms

CME Outfitters, LLC spinal muscular atrophy, neurology, neuroscience, spine, muscular atrophy, pediatrics, ob/gyn, neuro, SMA Free CE CME Live CE CME

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.